530
Views
40
CrossRef citations to date
0
Altmetric
Research Article

Medical Characteristics of Patients with Macular Telangiectasia Type 2 (MacTel Type 2) MacTel Project Report No. 3

, Ph.D., , M.D., Ph.D., , M.D., , M.D., , M.D., Ph.D., , MMed, PhD, , MD, PhD, , MD, MSc, , MD & show all
Pages 109-113 | Received 31 May 2012, Accepted 22 Oct 2012, Published online: 19 Mar 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Kerul Marsonia, Kedarisetti Kiran Chandra, M. Hasnat Ali, Jay Chhablani & Raja Narayanan. (2022) Long term follow-up of visual acuity and incidence of subretinal neovascularization in Mactel Type 2 in 82 Eyes. Seminars in Ophthalmology 37:2, pages 136-141.
Read now
Young Ho Kim, Yoo-Ri Chung, Jaeryung Oh, Seong-Woo Kim, Christopher Seungkyu Lee, Cheolmin Yun, Boram Lee, So Min Ahn, Eun Young Choi, Sungmin Jang & Kihwang Lee. (2021) Demographic and Multimodal Imaging Features of Macular Telangiectasia Type 2: Korean Macular Telangiectasia Type 2 Study – Report No. 2. Ophthalmic Epidemiology 28:5, pages 436-443.
Read now

Articles from other publishers (38)

Lydia Sauer, Alexandra S. Vitale, Rachael S. Jacoby, Barbara Hart & Paul S. Bernstein. (2023) FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY IN PATIENTS WITH MACULAR TELANGIECTASIA TYPE 2 WITH AND WITHOUT DIABETES. Retina 43:9, pages 1597-1607.
Crossref
Orlando G Gonzalez Martinez, Sofía C Ayala Rodríguez, Mariella Pappaterra-Rodriguez, Guillermo Requejo-Figueroa & Armando L Oliver. (2023) Intravitreal Bevacizumab for Choroidal Neovascular Membrane in Macular Telangiectasia Type 2. Cureus.
Crossref
Courtney R. Green, Roberto Bonelli, Brendan R.E. Ansell, Simone Tzaridis, Michal K. Handzlik, Grace H. McGregor, Barbara Hart, Jennifer Trombley, Mary M. Reilly, Paul S. Bernstein, Catherine Egan, Marcus Fruttiger, Martina Wallace, Melanie Bahlo, Martin Friedlander, Christian M. Metallo & Marin L. Gantner. (2023) Divergent amino acid and sphingolipid metabolism in patients with inherited neuro-retinal disease. Molecular Metabolism, pages 101716.
Crossref
Yan-Yu Chen, Yi-Ling Chen, Jian-Sheng Wu & San-Ni Chen. (2023) Clinical features of macular telangiectasia type 2 and comparison of staging system in Taiwanese patients. Taiwan Journal of Ophthalmology 13:3, pages 346.
Crossref
Anna A. Ledolter, Robin Ristl, Anja M. Palmowski‐Wolfe, Alessio Montuoro, Gabor G. Deak, Stefan Sacu, Graham E. Holder, Ursula Schmidt‐Erfurth & Markus Ritter. (2021) Macular Telangiectasia type 2: multimodal assessment of retinal function and microstructure. Acta Ophthalmologica 100:6.
Crossref
H.E. Tapia Quijada, C. Mantolan Sarmiento, S. Gómez Perera, M. Serrano García, N. Betancor Caro & B. Haro Álvarez. (2022) OCT-angiography for diagnosis and response to treatment of subretinal neovascularization secondary to idiopathic macular telangiectasia type 2. Archivos de la Sociedad Española de Oftalmología (English Edition) 97:4, pages 224-229.
Crossref
H.E. Tapia Quijada, C. Mantolan Sarmiento, S. Gómez Perera, M. Serrano García, N. Betancor Caro & B. Haro Álvarez. (2022) Angiografía-OCT para diagnóstico y respuesta al tratamiento de la neovascularización subretiniana secundaria a telangiectasia macular idiopática tipo 2. Archivos de la Sociedad Española de Oftalmología 97:4, pages 224-229.
Crossref
. 2022. The Fovea. The Fovea 187 241 .
Andreas Bringmann & Peter Wiedemann. 2022. The Fovea. The Fovea 139 185 .
Roberto Bonelli, Brendan R. E. Ansell, Luca Lotta, Thomas Scerri, Traci E. Clemons, Irene Leung, Tunde Peto, Alan C. Bird, Ferenc B. Sallo, Claudia Langenberg & Melanie Bahlo. (2021) Genetic disruption of serine biosynthesis is a key driver of macular telangiectasia type 2 aetiology and progression. Genome Medicine 13:1.
Crossref
Janice X. Ong, Roya Zandi & Amani A. Fawzi. (2021) Early-stage macular telangiectasia type 2 vascular abnormalities are associated with interdigitation zone disruption. PLOS ONE 16:11, pages e0259811.
Crossref
Saskia H.M. van Romunde, Charlotte M. van der Sommen, José P. Martinez Ciriano, Johannes R. Vingerling & Suzanne Yzer. (2021) Prevalence and Severity of Diabetic Retinopathy in Patients with Macular Telangiectasia Type 2. Ophthalmology Retina 5:10, pages 999-1004.
Crossref
Peixi Ying, Chang Huang, Yan Wang, Xi Guo, Yuchen Cao, Yuxi Zhang, Sheng Fu, Lin Chen, Guoguo Yi & Min Fu. (2021) Single-Cell RNA Sequencing of Retina:New Looks for Gene Marker and Old Diseases. Frontiers in Molecular Biosciences 8.
Crossref
Akihiro Shinkai, Wataru Saito, Yuki Hashimoto, Michiyuki Saito, Satoru Kase, Kousuke Noda & Susumu Ishida. (2020) Morphological features of macular telangiectasia type 2 in Japanese patients. Graefe's Archive for Clinical and Experimental Ophthalmology 259:5, pages 1179-1189.
Crossref
Kevin Eade, Marin L. Gantner, Joseph A. Hostyk, Takayuki Nagasaki, Sarah Giles, Regis Fallon, Sarah Harkins-Perry, Michelle Baldini, Esther W. Lim, Lea Scheppke, Michael I. Dorrell, Carolyn Cai, Evan H. Baugh, Charles J. Wolock, Martina Wallace, Rebecca B. Berlow, David B. Goldstein, Christian M. Metallo, Martin Friedlander & Rando Allikmets. (2021) Serine biosynthesis defect due to haploinsufficiency of PHGDH causes retinal disease. Nature Metabolism 3:3, pages 366-377.
Crossref
Stavros N. Moysidis, Nicole KoulisisPrethy RaoViren K. GovindarajuSamuel GamskyTamer H. MahmoudSandeep RandhawaLisa J. FaiaJeremy D. WolfeKimberly A. DrenserAlan J. RubyBruce R. GarretsonTarek S. HassanGeorge A. WilliamsMichael T. TreseAntonio Capone. (2021) PERIPHERAL RETINAL ANGIOGRAPHIC FINDINGS IN MACULAR TELANGIECTASIS TYPE 2. Retina 41:3, pages 480-486.
Crossref
Tjebo F.C. Heeren, Emily Y. Chew, Traci Clemons, Marcus Fruttiger, Konstantinos Balaskas, Roy Schwartz, Catherine A. Egan & Peter Charbel Issa. (2020) Macular Telangiectasia Type 2: Visual Acuity, Disease End Stage, and the MacTel Area. Ophthalmology 127:11, pages 1539-1548.
Crossref
Roberto Bonelli, Sasha M. Woods, Brendan R. E. Ansell, Tjebo F. C. Heeren, Catherine A. Egan, Kamron N. Khan, Robyn Guymer, Jennifer Trombley, Martin Friedlander, Melanie Bahlo & Marcus Fruttiger. (2020) Systemic lipid dysregulation is a risk factor for macular neurodegenerative disease. Scientific Reports 10:1.
Crossref
Wenjun Yan, Yi-Rong Peng, Tavé van Zyl, Aviv Regev, Karthik Shekhar, Dejan Juric & Joshua R. Sanes. (2020) Cell Atlas of The Human Fovea and Peripheral Retina. Scientific Reports 10:1.
Crossref
Matthew R. Starr, Raymond Iezzi & Sophie J. Bakri. (2020) Twenty-Year Incidence of Macular Telangiectasia Type 2 and Associated Systemic Comorbidities in Olmsted County, Minnesota. Ophthalmic Surgery, Lasers and Imaging Retina 51:S2.
Crossref
Richard F. Spaide. 2020. Macular Disorders. Macular Disorders 73 84 .
Matthew R. Starr & Sophie J. Bakri. 2020. Choroidal Neovascularization. Choroidal Neovascularization 179 186 .
Daniel Pauleikhoff, Roberto Bonelli, Adam M Dubis, Frederic Gunnemann, Kai Rothaus, Peter Charbel Issa, Tjebo FC Heeren, Tunde Peto, Traci E Clemons, Emily Y Chew, Alan C Bird & Ferenc B Sallo. (2019) Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2. Acta Ophthalmologica 97:7.
Crossref
Marin L. GantnerKevin EadeMartina WallaceMichal K. Handzlik, Regis FallonJennifer TrombleyRoberto BonelliSarah GilesSarah Harkins-PerryTjebo F.C. HeerenLydia SauerYoichiro IdeguchiMichelle BaldiniLea ScheppkeMichael I. DorrellMaki KitanoBarbara J. HartCarolyn CaiTakayuki NagasakiMehmet G. BadurMali OkadaSasha M. WoodsCatherine EganMark GilliesRobyn GuymerFlorian EichlerMelanie BahloMarcus FruttigerRando AllikmetsPaul S. BernsteinChristian M. MetalloMartin Friedlander. (2019) Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy. New England Journal of Medicine 381:15, pages 1422-1433.
Crossref
Vinod Kumar, Pradeep Kumar, Raghav Ravani & Prasad Gupta. (2018) Macular telangiectasia type II with pachychoroid spectrum of macular disorders. European Journal of Ophthalmology 29:2, pages 216-222.
Crossref
Talha Soorma, Tjebo HeerenDaniela Florea, Irene Leung & Tunde Peto. (2019) IDENTIFICATION OF INCREASED BLUE LIGHT REFLECTIVITY IN MACULAR TELANGIECTASIA TYPE 2 USING SCANNING LASER OPHTHALMOSCOPY VERSUS RED-FREE FUNDUS PHOTOGRAPHY. RETINAL Cases & Brief Reports 13:2, pages 115-117.
Crossref
Alejandra Daruich, Alexandre Matet, Alexandre Moulin, Laura Kowalczuk, Michaël Nicolas, Alexandre Sellam, Pierre-Raphaël Rothschild, Samy Omri, Emmanuelle Gélizé, Laurent Jonet, Kimberley Delaunay, Yvonne De Kozak, Marianne Berdugo, Min Zhao, Patricia Crisanti & Francine Behar-Cohen. (2018) Mechanisms of macular edema: Beyond the surface. Progress in Retinal and Eye Research 63, pages 20-68.
Crossref
Bindu Rajesh & Anantharaman Giridhar. (2018) YOUNGEST REPORTED CASE OF MACULAR TELANGIECTASIA (MAC TEL) TYPE 2. RETINAL Cases & Brief Reports 12:2, pages 115-117.
Crossref
Emily Y. Chew & Martin Friedlander. (2018) Global Connections to Study Idiopathic Macular Telangiectasia Type 2. Retina 38:1, pages S3-S7.
Crossref
Alexandre MatetSuzanne YzerEmily Y. ChewAlejandra DaruichFrancine Behar-CohenRichard F. Spaide. (2018) CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY. Retina 38:1, pages S67-S78.
Crossref
Tjebo F. C. HeerenDiána KitkaDaniela FloreaTraci E. ClemonsEmily Y. ChewAlan C. BirdDaniel PauleikhoffPeter Charbel Issa, Frank G. HolzTunde Peto. (2018) LONGITUDINAL CORRELATION OF ELLIPSOID ZONE LOSS AND FUNCTIONAL LOSS IN MACULAR TELANGIECTASIA TYPE 2. Retina 38:1, pages S20-S26.
Crossref
Stela VujosevicTjebo F. C. HeerenDaniela FloreaIrene LeungDaniel Pauleikhoff, Ferenc SalloAlan BirdTunde Peto. (2018) SCOTOMA CHARACTERISTICS IN MACULAR TELANGIECTASIA TYPE 2. Retina 38:1, pages S14-S19.
Crossref
Wenlan Zhang & Dilraj S. Grewal. 2018. Vitreoretinal Disorders. Vitreoretinal Disorders 91 131 .
Durgasri Jaisankar, Harshal Gondhale, Jay Chhablani, Manisha Agarwal & Rajiv Raman. (2017) Funduscopic and Angiographic Characteristics in Early and Late Macular Telangiectasia Type 2. Journal of VitreoRetinal Diseases 1:6, pages 372-378.
Crossref
Thomas S Scerri, Anna Quaglieri, Carolyn Cai, Jana Zernant, Nori Matsunami, Lisa Baird, Lea Scheppke, Roberto Bonelli, Lawrence A Yannuzzi, Martin Friedlander, Catherine A Egan, Marcus Fruttiger, Mark Leppert, Rando Allikmets & Melanie Bahlo. (2017) Genome-wide analyses identify common variants associated with macular telangiectasia type 2. Nature Genetics 49:4, pages 559-567.
Crossref
Anna Elias, Mahesh Gopalakrishnan & Giridhar Anantharaman. (2017) Risk factors in patients with macular telangiectasia 2A in an Asian population: A case–control study. Indian Journal of Ophthalmology 65:9, pages 830.
Crossref
Victor M. Villegas & Jaclyn L. Kovach. (2017) Optical Coherence Tomography Angiography of Macular Telangiectasia Type 2 with Associated Subretinal Neovascular Membrane. Case Reports in Ophthalmological Medicine 2017, pages 1-4.
Crossref
Min Zhao, Charlotte Andrieu-Soler, Laura Kowalczuk, María Paz Cortés, Marianne Berdugo, Marilyn Dernigoghossian, Francisco Halili, Jean-Claude Jeanny, Brigitte Goldenberg, Michèle Savoldelli, Mohamed El Sanharawi, Marie-Christine Naud, Wilfred van Ijcken, Rosanna Pescini-Gobert, Danielle Martinet, Alejandro Maass, Jan Wijnholds, Patricia Crisanti, Carlo Rivolta & Francine Behar-Cohen. (2015) A New CRB1 Rat Mutation Links Müller Glial Cells to Retinal Telangiectasia. The Journal of Neuroscience 35:15, pages 6093-6106.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.